The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
High blood pressure is one of the most common conditions affecting Americans. The CDC estimates that nearly half of adults in the US have hypertension. That comes out to 120 million people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results